Galderma's Nemluvio® (Nemolizumab) Approved In The European Union For Moderate-To-Severe Atopic Dermatitis And Prurigo N...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
AFP1d
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Vistagen advances Phase 3 SAD trials with 2025 data readout target
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
Contract Pharma2d
Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials
New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...
appliedclinicaltrialsonline5d
The Transformative Power of Data Analytics in Clinical Trials
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
BioXcel Therapeutics Provides Clinical and Business Update
Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or ...
The Lancet12d
Applying the estimand framework to inflammatory bowel disease clinical trials
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...
The Lancet14d
The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials
In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...
Nasdaq15d
Immutep Limited Announces Transition to Phase III with Regulatory Approval for TACTI-004 Trial in Non-Small Cell Lung Cancer
With a strong cash position of A$159.26 million, the company is well-funded for future operations and clinical trials. Immutep received regulatory approval for its pivotal TACTI-004 Phase III ...
NBC New York16d
FDA approves new type of nonopioid painkiller for acute pain
but there is no set definition for how long acute pain lasts. Vertex isn’t pursuing the FDA’s approval for suzetrigine to treat chronic pain — a phase 2 clinical trial looking at suzetrigine for ...
At 97 kg, she joined a clinical trial that redefines obesity. Now at 70 kg, this 48-year-old has reversed risks with a new protocol
“That’s why,” says Dr Naval Kishore Vikram, professor of medicine, Metabolic Research Group, AIIMS, “obesity has to be redefined for Indians (who have a higher fat mass than other populations) as it ...
GitHub23d
clinical-trial-management-system
LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).